All Type of News
Boehringer Ingelheim Korea appoints ‘Stephen Walter’ as new CEO
Boehringer Ingelheim Korea announced appointment of Stephen Walter as a new CEO of the company as of 1 June.
Stephen Walter has successfully contributed to growth of the company in the East Asian market as a general ...
JW Holdings acquires world’s first Japanese approval for early pancreatic cancer testing technology
JW Holdings was certified in novelty for its early pancreatic cancer diagnostic technology from the Japan Patent Office.
JW Holdings(CEO Sung-Kwon Han) announced on the 7th that the company has acquired Japanese appr...
111 drug supply suspensions last year
There were 111 pharmaceutical products which were reportedly suspended last year due to various factors, such as failure in controlling supply and demand and profitability.
Thus, the Ministry of Food and Drug Safety(...
Various routes to export pharmaceutical products to European market
Routes to export pharmaceutical products to the European market from Korea are getting more diverse.
This is because the GMP agreement with Switzerland, the strong power in the world’s pharmaceutical market, has made...
KPA, “There will be enough pharmacists in the future”
The Korean Pharmaceutical Association(KPA) submitted a research report about ‘There are enough pharmacists’ on the last 1st.
This is a follow-up measure to the Korea Institute for Health and Social Affairs’(KIHASA) s...
Hanmi Pharm cruising with global clinical trials of 3 next-gen anticancer drugs
The research data about drug candidates for next-generation anticancer drugs developed by Hanmi Pharm was presented at the 2018 American Society of Clinical Oncology held in Chicago between the last 1st and 5th.
The ...
Government to create direct communication channel about general and API approval
The Ministry of Food and Drug Safety will address issues in approval and assessment by creating a direct communication channel with the pharmaceutical industry.
In order to do so, first, the government will operate t...
‘Korea Night’ to introduce Korean state-of-the-art biologics in U.S.
A time was arranged to introduce status of the Korean state-of-the-art biologics development in Boston which has recently become an industrial hub for the U.S. biotechnology.
In Boston where almost a half of the worl...
Switzerland accepts excellent in Korean GMP system
The Ministry of Food and Drug Safety(MFDS) announced that they finally agreed to sign an agreement on mutual reliance(AMR) for GMP with Switzerland at the 6th Korea-EFTA FTA meeting on 6 June in Geneva, Switzerland.
...
Will MOHW’s visit to Japan bring positive impacts on Korean medical system?
While key health care divisions in the Ministry of Health and Welfare(MOHW) recently visited Japan, the industry is looking forwards to seeing if the visit would become a trigger for enhancement of the medical service...
